| Prev Close | 88.32 |
| Open | 88.53 |
| Day Low/High | 87.70 / 88.78 |
| 52 Wk Low/High | 55.36 / 90.61 |
| Volume | 5.20M |
CVS Health Corporation (CVS)
88.09
0.23
0.26
NYSE
| Exchange | NYSE |
| Shares Outstanding | 1319.58B |
| Market Cap | 115.70B |
| P/E Ratio | 12.25 |
| Div & Yield | N.A. (N.A) |
Latest News
Jim Cramer: The Days of Amazon as Death Star Are Over
Brick and Mortar strikes back.
Green Tuesday, Delta Economy, Policing Cryptos, Lockheed vs General Dynamics
The Delta virus has more power to control both fiscal and monetary policy than does the data or do any of our leaders individually.
Jim Cramer: I Love Seeing the Turnarounds Happen in Bed Bath & Beyond and IBM
I am betting with, not against, both CEOs. Too much good happening. Too little bad.
This Retailer Is Marching Toward Kingship
Walgreens Boots Alliance should benefit from an ageing population and increased demand for medications.
Let's Play 'Catch-Up' With Walgreens
With the shares stuck in a tight range, IV for WBA is cheap.
Jim Cramer: The Bears Are Fooling Themselves
Let's look at the many positive story lines out there -- which having nothing to do with the Fed -- and what they mean for investors.
Target and Darden Prove That Less Can Be More
TGT and DRI are two examples of companies that offloaded major divisions to make things better.
Riptide Market, Larry Summers on the Fed, Crypto Crackdown, Watching CVS
Do you know any business leaders? None of them are going to like the idea of higher corporate taxes. None of them.
Beat Estimates, See Multiple Expansion, Get 'Berry' Rich
Let look at a 1-2-3 strategy to make money, using Berry and CVS as examples.
Welcome to the Show, Trading FedEx and UPS, Vaccine Cavalry, Pfizer's Moment?
UPS and FDX are both in serious rally mode, yet in very different places in terms of technical development.
CVS Ups Earnings Guidance
CVS Health has upped its full-year 2021 GAAP diluted EPS guidance range to $6.24-$6.36 from $6.06 to $6.22 and its full-year 2021 Adjusted EPS guidance to $7.56 -$7.68 from $7.39- $7.55 and confirmed its full-year 2021 cash flow from operations guid...
All Aboard the Earnings Ship
Good morning folks, we've got a full day of earnings reports as well as a modicum of economic data on tap. I'll be your cruise director today, and yes, that is a slight nod to The Love Boat, which ran from 1976-1985. Some of the earnings reports I'l...
CVS and Walgreens Have the Right Prescription for Future Growth
Both stocks have been underperformers.
Will a Bounce in the Broken Be Used as an Escape Hatch?
What will really make a difference is if the strength holds, and there is a strong close.
Hall of Mirrors, Connecting the Fed Dots, National Debt Q&A, Amazon Disrupts
As a very wise man once said: 'I'll gladly pay you Tuesday for a hamburger today.'
Keep Ahead of the Turning Tide, or Get Washed Out
Here's how -- and why -- you should look at these value stocks instead of the Teslas and Zooms of the world.
True Value: My Stock Picks Have Average Returns of 100%+ Since October
While those Reddit traders lust over GameStop and other gambles, I've got my sights set on the long-term prize. Here's how you can, too.
Who Doesn't Like a Good 'Value'?
While those Reddit traders lust over GameStop and other gambles, I've got my sights set on the long-term prize. Here's how you can, too.
It's an Opportune Time to Renew Your Vows With CVS Health
The pharmacy giant offered a great buy/write options play last summer and is setting up again for such action.
CVS Health Reports Q4, and Here's What I'm Changing Up
I do want to give new CEO Karen Lynch a chance. Nothing against Larry Merlo but I always thought that this stock was undervalued.
CVS Health Charts Are Heading Higher
Continue to hold longs from our previous recommendation.
A Vote for Confidence, a Call to Work, a Little Light Reading, a Glance at Oil
Plus, we wait with great interest to learn what Berkshire Hathaway's holdings were as of the end of 2020.
Jim Cramer: Here Are the Biden Stocks
As power has changed hands in the White House, we can expect these names -- and themes -- to benefit.
This Dividend Aristocrat Would Be a Noble Addition to Your Portfolio
The company's size and scale are nearly unmatched in its sector.
CVS Health's Charts Are Close to an Important Breakout
Aggressive traders could go long CVS at current levels.
AbbVie Is a Stock to Position for 2021
Let's review the charts and indicators.
